Clinical Trials Browser

Phase 2 × Small Cell Lung Cancer Extensive Stage × sintilimab × Clear all

NCT04967625 2021-07-28

A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC

Phase 2 Unknown

Small Cell Lung Cancer Extensive Stage